Core Viewpoint - Univest Securities, LLC has successfully closed a registered direct offering of approximately $4.2 million for Boqii Holding Limited, a leading pet-focused platform in China [1][3]. Group 1: Offering Details - Boqii Holding Limited agreed to sell 1,500,000 Class A ordinary shares at a purchase price of $2.80 per share, or pre-funded warrants in lieu thereof [2]. - The total gross proceeds from the offering amounted to approximately $4.2 million [3]. - The offering was conducted under a shelf registration statement previously filed and declared effective by the SEC [4]. Group 2: Company Information - Boqii Holding Limited is recognized as a leading online destination for pet products in China, offering a wide range of high-quality products from global and local brands, as well as its own private labels [7]. - The company's online sales platforms, including Boqii Mall, provide customers with convenient access to pet products and an engaging shopping experience [7]. - Boqii also features a community platform for users to share knowledge and experiences related to pet care [7]. Group 3: Univest Securities Overview - Univest Securities, LLC has been registered with FINRA since 1994 and offers a variety of financial services, including investment banking and advisory [6]. - The firm has successfully raised over $1.7 billion in capital for issuers globally since 2019, completing approximately 100 transactions across various industries [6].

Core Viewpoint - Boqii Holding Ltd. has entered into a definitive agreement for a registered direct offering of 1,500,000 Class A ordinary shares at a price of $2.80 per share, expected to raise approximately $4.2 million in gross proceeds [1][2]. Group 1: Offering Details - The offering involves the sale of 1,500,000 Class A ordinary shares or pre-funded warrants at a purchase price of $2.80 per share [1]. - The transaction is anticipated to close on or about November 4, 2025, pending customary closing conditions [2]. - Univest Securities, LLC is acting as the sole placement agent for this offering [2]. Group 2: Regulatory Information - The offering is made pursuant to a shelf registration statement on Form F-3, which was declared effective by the SEC on November 23, 2022 [3]. - A final prospectus supplement and accompanying prospectus will be filed with the SEC and will be available on the SEC's website [3]. Group 3: Company Overview - Boqii Holding Ltd. is a leading pet-focused platform in China, offering a wide selection of pet products, including global and local brands as well as its private labels [5]. - The company operates online sales platforms such as Boqii Mall and provides an engaging shopping experience for customers [5]. - Boqii Community serves as an interactive content platform for pet lovers to share knowledge and experiences [5].

Core Points - Ekso Bionics Holdings, Inc. has entered into a definitive agreement for the purchase and sale of 769,490 shares of common stock at a price of $4.81 per share, expected to close around October 30, 2025 [1] - The gross proceeds from this offering are anticipated to be $3.7 million, which will be used for general corporate purposes including research and development, administrative costs, and working capital needs [3] - The shares are being offered under a "shelf" registration statement previously filed with the SEC, and the offering will be conducted via a prospectus [4] Company Overview - Ekso Bionics is a leading developer of exoskeleton solutions aimed at enhancing human strength, endurance, and mobility for both medical and industrial applications [6] - The company focuses on improving health and quality of life through advanced robotics, and is recognized for its unique technologies that assist individuals with paralysis and enhance capabilities in various job sites [6] - Ekso Bionics is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol "EKSO" [6]

Core Points - T1 Energy Inc. has announced a registered direct offering of common stock, aiming to raise gross proceeds of $72 million [1][2] - The company will issue 22,153,850 shares at a price of $3.25 per share [2] - The offering is expected to close on or about October 24, 2025, subject to customary closing conditions [2] Financial Details - After the offering, T1 Energy will have approximately $155 million in cash, cash equivalents, and restricted cash, with $102 million being unrestricted [2] - The proceeds from the offering will be utilized for strategic investments, partnership development, and advancements in energy technology and infrastructure projects [8] Company Background - T1 Energy Inc. is focused on building an integrated U.S. supply chain for solar and batteries, having completed a transformative transaction in December 2024 [6] - The company is positioned as a leading solar manufacturing entity in the U.S. and is exploring value optimization opportunities in Europe [6]

Core Points - XORTX Therapeutics Inc. has entered into a securities purchase agreement for the sale of 1,746,631 common shares at a price of US$0.63 per share, aiming to raise gross proceeds of US$1.1 million [1][2] Group 1: Offering Details - The closing of the offering is expected on or about October 22, 2025, pending customary closing conditions and TSX Venture Exchange approval [2] - The net proceeds from the offering will be used for working capital and general corporate purposes [2] - D. Boral Capital LLC is acting as the sole placement agent for the offering [3] Group 2: Regulatory Information - The common shares will be issued under an effective shelf registration statement previously filed with the SEC [4] - A prospectus supplement detailing the terms of the offering will be filed with the SEC and will be available on their website [4] Group 3: Company Overview - XORTX is focused on developing therapies for gout and progressive kidney disease, with three clinically advanced products: XRx-026 for gout, XRx-008 for ADPKD, and XRx-101 for acute kidney injury [6] - The company is also developing XRx-225, a pre-clinical program for Type 2 diabetic nephropathy [6] - XORTX aims to improve the quality of life for individuals with gout and related diseases by targeting purine metabolism and xanthine oxidase to reduce uric acid production [6]

Core Viewpoint - UTime Limited has entered into a definitive securities purchase agreement with five institutional investors for the purchase of 22,727,275 units, which include Class A ordinary shares and Series A warrants, at a price of $1.10 per unit, aiming to raise approximately $25 million in gross proceeds [1][2][3]. Group 1: Offering Details - The offering consists of Class A ordinary shares and Series A warrants, with each warrant having an exercise price of $1.10 per share and expiring six months after issuance [3]. - The transaction is expected to close around October 17, 2025, pending customary closing conditions [3]. - The offering is conducted under a shelf registration statement previously filed and declared effective by the SEC [4]. Group 2: Company Overview - UTime Limited specializes in consumer electronics and mobile communications, focusing on the design, development, and manufacture of smartphones, feature phones, and related accessories [6]. - The company operates through both OEM/ODM services and proprietary brands, providing end-to-end product solutions that include hardware design, software customization, and after-sales support [6]. - UTime's principal business activities include contract manufacturing, in-house development of smart devices, integration of new technologies like IoT and 5G, and supply-chain management services [6].

Core Viewpoint - Big Tree Cloud Holdings Limited has successfully completed a registered direct offering, raising approximately $5.0 million through the sale of 8,064,516 ordinary shares at a price of $0.62 per share [1][2]. Company Overview - Big Tree Cloud, founded in 2020, is an international capital platform focused on strategic investment and industrial integration within China's personal care industry. The company emphasizes scientific research, innovation, and technological advancement, aiming to enhance supply chain synergy and improve efficiency [5]. Offering Details - The offering was conducted with Aegis Capital Corp. as the exclusive placement agent, and the gross proceeds before fees and expenses amounted to approximately $5.0 million [2][3]. - The offering was made under an effective shelf registration statement filed with the U.S. Securities and Exchange Commission (SEC) [3]. Use of Proceeds - The net proceeds from the offering are expected to be utilized for general corporate purposes and working capital [2].

Core Viewpoint - WORK Medical Technology Group LTD has announced a registered direct offering of 38,999,334 Class A ordinary shares at a price of $0.075 per share, aiming to raise approximately $2.9 million in gross proceeds [1][2]. Group 1: Offering Details - The offering involves the sale of Class A ordinary shares or pre-funded warrants at a purchase price of $0.075 per share, with the pre-funded warrants having an exercise price of $0.0005 per share [1]. - The transaction is expected to close on or about September 26, 2025, pending customary closing conditions [2]. - The offering is made under a shelf registration statement on Form F-3, which was declared effective by the SEC on September 15, 2025 [3]. Group 2: Company Overview - WORK Medical Technology Group LTD, through its subsidiary, develops and manufactures Class I and II medical devices, with a diverse product portfolio of 21 products, including customized masks and medical consumables [5]. - The company has sold products in 34 provincial-level regions in China and has 15 products available in over 30 countries globally [5]. - WORK Medical has received various quality-related manufacturing designations and has registered 17 products with the U.S. FDA, allowing entry into the U.S. market [5].

Core Viewpoint - Boxlight Corporation has announced a registered direct offering of common stock, aiming to raise approximately $4 million through the sale of 1,333,333 shares at a price of $3.00 per share [1]. Group 1 - Boxlight Corporation is recognized as a leader in educational technology on a global scale [1]. - The securities purchase agreements were made with certain institutional investors [1]. - The offering is priced at-the-market under Nasdaq rules [1].

Core Viewpoint - Ryde Group Ltd has announced a securities purchase agreement to raise approximately US$1.6 million through the sale of Class A shares at US$0.25 each [1] Group 1: Company Overview - Ryde Group Ltd is a leading technology platform for mobility and quick commerce, headquartered in Singapore [1] - The company is listed on NYSE American under the ticker symbol RYDE [1] Group 2: Financial Details - The offering consists of 6,422,000 Class A shares [1] - The gross proceeds from the offering are approximately US$1.6 million before deducting offering expenses [1] - The offering is a registered direct offering priced at-the-market under NYSE American rules [1] Group 3: Offering Structure - The company did not engage any placement agent for the offering [1]